Literature DB >> 26139021

Pulmonary enteric adenocarcinoma.

Yoshinori Handa1, Yuichiro Kai2, Takuhiro Ikeda2, Hidenori Mukaida2, Hiromi Egawa3, Mayumi Kaneko3.   

Abstract

A 70-year-old man was referred to our department due to abnormal shadows on a chest radiograph. Computed tomography of the chest revealed a 3-cm nodule in the right middle lung lobe, and bronchoscopy revealed adenocarcinoma cells with EGFR mutations. A lung resection was performed. Histological analysis revealed tumors comprising tall columnar cells that were similar to an adenocarcinoma of the sigmoid colon that had been resected 13 years previously. Metastatic colorectal carcinoma was initially considered, but immunohistochemical staining indicated pulmonary enteric adenocarcinoma. Pulmonary enteric adenocarcinoma was first described in 1991, and about 30 cases have since been described in the English literature. However, its concept and etiology are not clear. It is important to distinguish pulmonary enteric adenocarcinoma from metastatic colorectal carcinoma because of obvious differences in therapeutic strategies and prognosis, especially with a past history of colorectal carcinoma. Immunohistochemical and gene mutation analyses seemed to be helpful.

Entities:  

Keywords:  Enteric adenocarcinoma; Immunohistochemical staining; Lung cancer; Metastatic colorectal carcinoma

Mesh:

Year:  2015        PMID: 26139021     DOI: 10.1007/s11748-015-0569-0

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  5 in total

1.  Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.

Authors:  William D Travis; Elisabeth Brambilla; Allen P Burke; Alexander Marx; Andrew G Nicholson
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

2.  Pulmonary adenocarcinomas with enteric differentiation: histologic and immunohistochemical characteristics compared with metastatic colorectal cancers and usual pulmonary adenocarcinomas.

Authors:  Kentaro Inamura; Yukitoshi Satoh; Sakae Okumura; Ken Nakagawa; Eiju Tsuchiya; Masashi Fukayama; Yuichi Ishikawa
Journal:  Am J Surg Pathol       Date:  2005-05       Impact factor: 6.394

3.  Pulmonary intestinal-type adenocarcinoma does not show enteric differentiation by immunohistochemical study.

Authors:  Samuel A Yousem
Journal:  Mod Pathol       Date:  2005-06       Impact factor: 7.842

4.  Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification.

Authors:  William D Travis; Elisabeth Brambilla; Masayuki Noguchi; Andrew G Nicholson; Kim Geisinger; Yasushi Yatabe; Yuichi Ishikawa; Ignacio Wistuba; Douglas B Flieder; Wilbur Franklin; Adi Gazdar; Philip S Hasleton; Douglas W Henderson; Keith M Kerr; Yukio Nakatani; Iver Petersen; Victor Roggli; Erik Thunnissen; Ming Tsao
Journal:  Arch Pathol Lab Med       Date:  2012-09-12       Impact factor: 5.534

5.  Pulmonary intestinal-type adenocarcinoma.

Authors:  Ryo Maeda; Noritaka Isowa; Hideyuki Onuma; Hiroshi Miura
Journal:  Interact Cardiovasc Thorac Surg       Date:  2008-01-09
  5 in total
  3 in total

1.  Pulmonary enteric adenocarcinoma with pancreatic metastasis: A case report.

Authors:  Wen-Wen Sun; Zhi-Hong Xu; Chao-Fu Wang; Fang Wu; Jiu-Mei Cao; Pei-Jing Cui; Wei Huang; Xiao-Long Jin; Biao Li; Ke-Min Chen; Bei-Li Gao; Jia-An Hu
Journal:  Oncol Lett       Date:  2017-04-20       Impact factor: 2.967

2.  Combination of Pembrolizumab With Platinum-containing Chemotherapy for Pulmonary Enteric Adenocarcinoma.

Authors:  Shuhei Teranishi; Chihiro Sugimoto; Hirokazu Nagayama; Wataru Segawa; Atsushi Miyasaka; Shuntaro Hiro; Chihiro Maeda; Hironori Tamura; Nami Masumoto; Yoshinori Nagahara; Nobuyuki Hirama; Nobuaki Kobayashi; Masaki Yamamoto; Makoto Kudo; Takeshi Kaneko
Journal:  Cancer Diagn Progn       Date:  2022-03-03

3.  Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy.

Authors:  Ming Chen; Pu Liu; Feifei Yan; Suzhen Xu; Qi Jiang; Jingying Pan; Mengye He; Peng Shen
Journal:  J Transl Med       Date:  2018-03-27       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.